如何提高类风湿关节炎高危人群参与预防试验的招募率:障碍与促进因素的定性研究
该定性研究通过焦点小组讨论(n=18)探讨了类风湿关节炎高危个体(抗瓜氨酸化蛋白抗体和/或类风湿因子阳性但无关节炎的关节痛患者)参与预防试验的障碍与促进因素。主题分析发现个人获益前景、症状被认可及贡献社会的愿望促进参与,而对风险含义或试验目的的误解、对试验药物的负面看法、感知紧迫性低与试验负担高则阻碍参与。结果提示优化教育、明确处理误解与顾虑、限制研究负担及鼓励医生提及试验参与可增强招募。
要点
- 个人获益、症状被认可和贡献社会是高危个体参与预防试验的主要促进因素。
- 对风险含义和试验目的的误解、对试验药物的负面看法是主要障碍。
- 感知类风湿关节炎风险紧迫性低而试验负担高会降低参与意愿。
核心结论
- 为增强类风湿关节炎预防试验的招募,建议采用优化类风湿关节炎、个人风险、试验目的和试验药物教育等策略。
- 应明确处理误解与顾虑,使用工具改善信息提供,限制试验设计中的研究负担,并鼓励医生提及试验参与。
研究设计与样本
- 定性研究,对18名曾受邀参与预防试验的类风湿关节炎高危个体(抗瓜氨酸化蛋白抗体和/或类风湿因子阳性但无关节炎的关节痛患者)进行焦点小组讨论。
- 采用主题分析识别影响高危个体参与试验决策的重要因素。
主要发现
- 个人获益前景、症状被认可和贡献社会的愿望促进试验参与。
- 对风险含义或预防试验目的的误解、对试验药物的负面看法阻碍参与。
- 对发展为类风湿关节炎可能性感知紧迫性低而参与试验感知负担高,会阻碍参与。
临床怎么用
- 优化关于类风湿关节炎、个人风险、试验目的和试验药物的教育。
- 明确处理误解与顾虑,使用工具改善信息提供。
- 在试验设计中限制研究负担,并鼓励医生提及试验参与。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Several trials to test the efficacy of a pharmacological intervention aimed at primary prevention of rheumatoid arthritis (RA) are ongoing or have recently been completed. A common issue in these trials is the severe difficulty with patient recruitment. In order to enhance recruitment, this qualitative study identified barriers and facilitators of individuals at risk of RA to participate in a prevention trial. METHODS: Individuals at risk of developing RA (ie, arthralgia with anticitrullinated protein antibodies and/or rheumatoid factor without arthritis), who had previously been asked to participate in a prevention trial, participated in focus group discussions (n=18) exploring their facilitators and barriers for trial participation. Thematic analysis identified factors that were important in at-risk individuals' decision about trial participation. RESULTS: The prospect of personal benefit, the acknowledgement of one's symptoms and the desire to contribute to society facilitated trial participation. In contrast, misconception about what it means to be at risk, or about the aim of the prevention trial, negative views on trial medication, and a low perceived urgency to act on the possibility of developing RA versus a high perceived burden of participating in a trial discouraged participation. CONCLUSIONS: To enhance inclusion in trials aimed to prevent RA, the results suggest to use strategies such as optimising education about RA, personal risk, trial aim and trial medication, explicitly addressing misconceptions and concerns, using tools to improve information provision, limiting study burden in trial design and encouraging physicians to mention trial participation.
引用
- van Boheemen L, Ter Wee MM, Seppen B, et al. How to enhance recruitment of individuals at risk of rheumatoid arthritis into trials aimed at prevention: understanding the barriers and facilitators. RMD Open. 2021. PMID: 33685929. doi:10.1136/rmdopen-2021-001592
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。